Primary Chemoablation of Recurrent Low-Grade Intermediate-Risk Nonmuscle-Invasive Bladder Cancer With UGN-102: A Single-Arm, Open-Label, Phase 3 Trial (ENVISION).
Prasad SM, Shishkov D, Mihaylov NV, Khuskivadze A, Genov P, Terzi V, Kates M, Huang WC, Louie MJ, Raju S, Burger B, Meads A, Schoenberg M.
J Urol. 2025 Feb;213(2):205-216. doi: 10.1097/JU.0000000000004296. Epub 2024 Oct 24.
PMID:39446087
Management of Urethral Hemangioma.
Alam R, Rostom M, Cohen AJ.
Urology. 2022 Feb;160:227. doi: 10.1016/j.urology.2021.10.027. Epub 2021 Nov 13.
PMID:34780843
The Impact of En-bloc Transurethral Resection of Bladder Tumour on Clinical, Pathological and Oncological Outcomes: A Cohort Study.
Kannan D, Sekaran PG, Sankaran S, Taur P, J SP, Paul R, Thangarasu M, Jain N.
The effect of holmium laser resection versus standard transurethral resection on non-muscle-invasive bladder cancer: a systematic review and meta-analysis.
Li C, Gao L, Zhang J, Yang X, Liu C.
Lasers Med Sci. 2020 Jul;35(5):1025-1034. doi: 10.1007/s10103-020-02972-w. Epub 2020 Jan 31.
PMID:32006262
Risk factors for bladder neck contracture after transurethral resection of the prostate.
Goßler C, Pfänder F, Haas M, Mayr R, Gierth M, Burger M, Rosenhammer B, Breyer J.
Bladder perforation as a complication of transurethral resection of bladder tumors: the predictors, management, and its impact in a series of 1570 at a tertiary urology institute.
Osman Y, Elawdy M, Taha DE, Zahran MH, Abouelkheir RT, Sharaf DE, Mosbah A, Ali-El Dein B.
Int Urol Nephrol. 2023 Sep;55(9):2161-2167. doi: 10.1007/s11255-023-03638-6. Epub 2023 Jun 15.
PMID:37318699
Efficacy of the Treatment of Intraperitoneal Bladder Perforation during Transurethral Resection of Bladder Tumor with the Urethral Catheter Alone: Retrospective Analysis of over 15 Years Using the Clinical Data Warehouse System.